hTERT peptide-based vaccine (Invectys)

N/A

Report date: 2026/02/13 20:01:31

Base Information

Drug NamehTERT peptide-based vaccine (Invectys)
Drug Alias NameHuman telomerase reverse transcriptase peptide-based vaccinehTERT prptide vaccineUCPVax
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionHuman telomerase (hTERT)-directed cytolytic effectsImmunostimulants
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInvectys
China Registration ClassN/A

Develop Information

Active CompaniesInvectysMerck Sharp & Dohme LLC
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A